Muscular dystrophy protein, dystrophin
AssigneeChildren's Medical Center Corporation
InventorsLouis M. Kunkel, Anthony Monaco, Eric P. Hoffman, Michel Koenig
Life of this patent
Estimating the term…
Abstract
The invention relates to a muscular dystrophy (MD) probe comprising a substantially purified single-stranded nucleic acid sequence capable of hybridizing to a region of DNA on a human X chromosome between the deletion break point at Xp21.3 and the translocation break point at X;11. The invention also relates to a 14 kb cDNA corresponding to the complete MD gene and probes produced therefrom useful in genetic methods of diagnosis of MD. Furthermore, the invention relates to the polypeptide, dystrophin, which corresponds to the MD gene product, and antibodies thereto that are useful in a variety of methods for immunodiagnosis of MD.
Claims5
A composition comprising dystrophin and lacking at least some components of the environment in which dystrophin naturally occurs, said dystrophin being characterized by:
- a) an apparent molecular weight of about 400 kd when measured by SDS-polyacrylamide gel electrophoresis;
- b) obtainability from muscle tissue;
- and c) insolubility in nonionic detergent.
A composition comprising a dystrophin fragment and lacking at least some components of the environment in which dystrophin naturally occurs, said dystrophin fragment being immunologically cross-reactive with dystrophin, said dystrophin being characterized by:
- a) an apparent molecular weight of about 400 kd when measured by SDS-polyacrylamide gel electrophoresis;
- b) obtainability from muscle tissue;
- and c) insolubility in a nonionic detergent.
Dependencies are inferred from the claim text.